Halil BAŞAR, Aykut DEMİRCİ, Fatih HIZLI, İsa DAĞLI

Transrektal prostat biyopsisinin çiftlerin seksüel fonksiyonları üzerine etkisi

AMAÇ: Transrektal prostat biyopsisi prostat kanseri tanısında sıklıkla kullanılmaktadır. Fakat işlem sonrası hastalar erektil disfonksiyon (ED) riski ile karşılaşmaktadır. Erektil disfonksiyon ayrıca hastaların partner- lerinin de yaşam kalitesini olumsuz yönde etkilenmektedir. Biz de çalış- mamızda transrektal prostat biyopsisi sonrası çiftlerin cinsel yaşamının nasıl etkilendiğini araştırmayı amaçladık. GEREÇ ve YÖNTEMLER: Ekim 2021-Haziran 2022 tarihleri arasında ilk kez transrektal prostat biyopsisi yapılan hastalar (s=72) ve onların partnerleri çalışmaya alındı. Cinsel fonksiyonlardaki birinci, üçüncü ve altıncı aylardaki değişim erkek hastalarda Uluslararası Erektil İşlev Formunda (IIEF-15) Erektil Fonksiyon (EF) skorları ile, kadın partner- lerde Kadın Cinsel Fonksiyon İndeksi (FSFI) ve Kadın Cinsel Sıkıntı Envanteri (FSDS) anketleri ile değerlendirildi. BULGULAR: Hastaların yaş ortalaması 63,47±5,09’du. Biyopsi sonrası yeni ED tanısı alanların oranı %19,4’tü. Median EF skorunda 1. ayda biyopsi öncesine göre düşüş olduğu [ 8,5 (11), 18 (15), p

The effect of transrectal prostate biopsy on sexual functions of couples

OBJECTIVE: Transrectal prostate biopsy is frequently used in the diagnosis of prostate cancer. However, after the procedure, patients face the risk of erectile dysfunction (ED). Erectile dysfunction also negatively affects the quality of life of patients’ partners. In our study, we aimed to investigate how the sexual life of couples is affected after transrectal prostate biopsy. MATERIAL and METHODS: Patients (n=72) who underwent transrectal prostate biopsy for the first time between October 2021 and June 2022 and their partners were included in the study. Changes in sexual functions in the first, third and sixth months were evaluated with the International Erectile Function Form (IIEF-15) Erectile Function (EF) scores in male patients, and the Female Sexual Function Index (FSFI) and Female Sexual Distress Inventory (FSDS) questionnaires in female partners. RESULTS: The mean age of the patients was 63.47±5.09 years. The rate of newly diagnosed ED after the biopsy was 19.4%. It was observed that there was a decrease in the median EF scores in the 1st month compared to the pre-biopsy [8.5 (11), 18 (15), p

PDF

___

1. Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol 2020;77(1):38–52. [CrossRef ]
2. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120– 34. [CrossRef ]
3. Farrell C, Noyesa SL, Joslin J, Varma M, Moriarity A, Buchach C, et al. Prostate Multiparametric Magnetic Resonance Imaging Program Implementation and Impact: Initial Clinical Experience in a Community Based Health System. Urology Practice. 2018;5(3):165–71. [CrossRef ]
4. Udeh EI, Amu OC, Nnabugwu II, Ozoemena O. Transperineal versus transrectal prostate biopsy: our findings in a tertiary health institution. Niger J Clin Pract. 2015;18(1):110–4. [CrossRef ]
5. Salonia A, Castagna G, Saccà A, Ferrari M, Capitanio U, Castiglione F, et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. J Sex Med. 2012;9(10):2708– 15. [CrossRef ]
6. Fisher WA, Eardley I, McCabe M, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples I. couple conceptions of ED. J Sex Med. 2009;6(10):2746–60. [CrossRef ]
7. Glaser AP, Novakovic K, Helfand BT. The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety. Curr Urol Rep. 2012;13(6):447–54. [CrossRef ]
8. Mehta A, Kim WC, Aswad KG, Brunckhorst O, Ahmed HU, Ahmed K. Erectile Function Post Prostate Biopsy: A Systematic Review and Meta-analysis. Urology. 2021;155:1–8. [CrossRef ]
9. Aydemir Ö, Güvenir T, Küey L, Kültür S. Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale. Turk J Psychiatry. 1997;8(4):280–7. https://www.researchgate. net/publication/301778685_Hastane_Anksiyete_ve_Depresyon_ Olcegi_Turkce_Formunun_Gecerlilik_ve_Guvenilirlik_ Calismasi_Reliability_and_Validity_of_the_Turkish_version_of_ Hospital_Anxiety_and_Depression_Scale
10. Aydın S, Onaran ÖI, Topalan K, Arıoğlu Aydın Ç, Dansuk R. Development and Validation of Turkish Version of The Female Sexual Distress Scale-Revised. Sex Med. 2016;4(1):e43–50. [CrossRef]
11. Linden-Castro E, Pelayo-Nieto M, Espinosa-Perezgrovas D, Rubio-Arellano ED, Catalán-Quinto G, Guzmán-Hernández F, et al. Impacto de la biopsia transrectal de próstata en la función eréctil. Actas Urol Esp. 2016;40(7):453–6. [CrossRef ]
12. García Rojo E, García Gómez B, Padilla G, Abad López P, García González L, Rodríguez Antolín A, Romero Otero J. Assessment of the influence of transrectal and transperineal prostate biopsies on erectile function: A prospective observational single-center study. Int J Urol. 2019;26(11):1054–8. [CrossRef ]
13. Macefield RC, Metcalfe C, Lane JA, Donovan JL, Avery KN, Blazeby JM, et al.; ProtecT Study Group. Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Cancer. 2010;102(9):1335–40. [CrossRef ]
14. Bill-Axelson A, Garmo H, Lambe M, Bratt O, Adolfsson J, Nyberg U, et al. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol. 2010;57(3):390–5. [CrossRef ]
15. Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, et al. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int. 2006;98(4):777–82. [CrossRef ]
16. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54– 61. [CrossRef ]
17. Chapple C, Abrams P, editors. Male Lower Urinary Tract Symptoms (LUTS): An International Consultation on Male LUTS. Société Internationale d’Urologie (SIU); 2013. https://www.siu-urology. org/themes/web/assets/files/ICUD/pdf/Male%20Lower%20 Urinary%20Tract%20Symptoms%20(LUTS).pdf
18. Cayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner’s sexual functions? J Sex Marital Ther. 2004;30(5):333–41. [CrossRef ]
19. Tuncel A, Kirilmaz U, Nalcacioglu V, Aslan Y, Polat F, Atan A. The impact of transrectal prostate needle biopsy on sexuality in men and their female partners. Urology. 2008;71(6):1128–31. [CrossRef]
20. van Hove A, Savoie PH, Maurin C, Brunelle S, Gravis G, Salem N, Walz J. Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies. World J Urol. 2014;32(4):847–58. [CrossRef ]